Literature DB >> 20125172

Epidemiology: Interpreting studies of interactions between RA risk factors.

Elizabeth W Karlson1, Karen H Costenbader.   

Abstract

Interactions between HLA and PTPN22 genotypes and smoking have been implicated in overall susceptibility to rheumatoid arthritis as well as the incidence of particular disease phenotypes in case-control and case-only studies. As recent epidemiological evidence shows, deciphering these interactions demands consideration of the analytical approach used.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20125172     DOI: 10.1038/nrrheum.2009.276

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  9 in total

1.  Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women.

Authors:  Karen H Costenbader; Diane Feskanich; Lisa A Mandl; Elizabeth W Karlson
Journal:  Am J Med       Date:  2006-06       Impact factor: 4.965

2.  A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.

Authors:  Lars Klareskog; Patrik Stolt; Karin Lundberg; Henrik Källberg; Camilla Bengtsson; Johan Grunewald; Johan Rönnelid; Helena Erlandsson Harris; Ann-Kristin Ulfgren; Solbritt Rantapää-Dahlqvist; Anders Eklund; Leonid Padyukov; Lars Alfredsson
Journal:  Arthritis Rheum       Date:  2006-01

3.  Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Authors:  S P Linn-Rasker; A H M van der Helm-van Mil; F A van Gaalen; M Kloppenburg; R R P de Vries; S le Cessie; F C Breedveld; R E M Toes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

4.  Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis.

Authors:  Henrik Kallberg; Leonid Padyukov; Robert M Plenge; Johan Ronnelid; Peter K Gregersen; Annette H M van der Helm-van Mil; Rene E M Toes; Tom W Huizinga; Lars Klareskog; Lars Alfredsson
Journal:  Am J Hum Genet       Date:  2007-04-02       Impact factor: 11.025

5.  Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.

Authors:  Jonathan A Hill; Scott Southwood; Alessandro Sette; Anthony M Jevnikar; David A Bell; Ewa Cairns
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

6.  Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Authors:  Ann W Morgan; Wendy Thomson; Stephen G Martin; Angela M Carter; Henry A Erlich; Anne Barton; Lynne Hocking; David M Reid; Pille Harrison; Paul Wordsworth; Sophia Steer; Jane Worthington; Paul Emery; Anthony G Wilson; Jennifer H Barrett
Journal:  Arthritis Rheum       Date:  2009-09

7.  A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis.

Authors:  Leonid Padyukov; Camilla Silva; Patrik Stolt; Lars Alfredsson; Lars Klareskog
Journal:  Arthritis Rheum       Date:  2004-10

8.  Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.

Authors:  Hye-Soon Lee; Patricia Irigoyen; Marlena Kern; Annette Lee; Franak Batliwalla; Houman Khalili; Frederick Wolfe; Raymond F Lum; Elena Massarotti; Michael Weisman; Claire Bombardier; Elizabeth W Karlson; Lindsey A Criswell; Robert Vlietinck; Peter K Gregersen
Journal:  Arthritis Rheum       Date:  2007-06

9.  Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis.

Authors:  E W Karlson; S-C Chang; J Cui; L B Chibnik; P A Fraser; I De Vivo; K H Costenbader
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

  9 in total
  6 in total

Review 1.  Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.

Authors:  Frederick W Miller; Lars Alfredsson; Karen H Costenbader; Diane L Kamen; Lorene M Nelson; Jill M Norris; Anneclaire J De Roos
Journal:  J Autoimmun       Date:  2012-06-25       Impact factor: 7.094

Review 2.  Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases.

Authors:  Jeffrey A Sparks; Karen H Costenbader
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

Review 3.  [Treat to target and personalized medicine (precision medicine)].

Authors:  J Detert; G R Burmester
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

4.  End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.

Authors:  Linda T Hiraki; Bing Lu; Steven R Alexander; Tamara Shaykevich; Graciela S Alarcón; Daniel H Solomon; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2011-07

5.  Gene-gene interaction of BLK, TNFSF4, TRAF1, TNFAIP3, and REL in systemic lupus erythematosus.

Authors:  Xu-jie Zhou; Xiao-lan Lu; Swapan K Nath; Ji-cheng Lv; Sai-nan Zhu; Hai-zhen Yang; Lian-xiang Qin; Ming-hui Zhao; Yin Su; Nan Shen; Zhan-guo Li; Hong Zhang
Journal:  Arthritis Rheum       Date:  2012-01

6.  Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Authors:  Jianxun Wang; Masayuki Mizui; Li-Fan Zeng; Roderick Bronson; Michele Finnell; Cox Terhorst; Vasileios C Kyttaris; George C Tsokos; Zhong-Yin Zhang; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.